期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
内皮素及降钙素基因相关肽在感染性胆汁中的变化及意义(摘要)
1
作者 李波 夏先明 张陪明 《泸州医学院学报》 2001年第5期372-372,共1页
关键词 感染性胆汁 胆结石 内皮素 降钙素基因相关肽
下载PDF
更昔洛韦治疗婴儿巨细胞病毒感染相关胆汁淤积性肝炎的疗效分析 被引量:5
2
作者 黄丽 《广西医科大学学报》 CAS 2015年第4期636-638,共3页
目的:探讨更昔洛韦(GCV)在治疗婴儿巨细胞病毒感染相关胆汁淤积性肝炎的抗病毒疗效。方法:将155例巨细胞病毒感染相关胆汁淤积性肝炎患儿,随机分为治疗组和对照组,在基础治疗上,治疗组给予GCV抗病毒治疗,对照组未予GCV治疗,观察两组的... 目的:探讨更昔洛韦(GCV)在治疗婴儿巨细胞病毒感染相关胆汁淤积性肝炎的抗病毒疗效。方法:将155例巨细胞病毒感染相关胆汁淤积性肝炎患儿,随机分为治疗组和对照组,在基础治疗上,治疗组给予GCV抗病毒治疗,对照组未予GCV治疗,观察两组的临床疗效。结果:治疗组与对照组治疗前后肝功能、痊愈率、好转率、无效率等比较差异均无统计学意义(均P>0.05)。结论:GCV治疗婴儿巨细胞病毒感染相关性胆汁淤积性肝炎不能增加临床好转率及肝功能改善情况。 展开更多
关键词 婴儿 巨细胞病毒感染相关胆汁淤积肝炎 更昔洛韦
下载PDF
胆汁细菌性感染时血浆内毒素水平的变化 被引量:1
3
作者 黄惠泉 龚国光 潘旷怡 《咸宁医学院学报》 2000年第2期107-109,共3页
目的 :研究胆汁在不同类型的细菌感染时血浆内毒素含量的变化。方法 :胆囊切除术中取胆汁作细菌培养和涂片染色镜检。革兰氏阴性菌感染者 ( 40例 )、革兰氏阳性菌感染者 ( 40例 )和菌检阴性者 (对照组 4 0例 )共 1 2 0例 ,均在胆囊切除... 目的 :研究胆汁在不同类型的细菌感染时血浆内毒素含量的变化。方法 :胆囊切除术中取胆汁作细菌培养和涂片染色镜检。革兰氏阴性菌感染者 ( 40例 )、革兰氏阳性菌感染者 ( 40例 )和菌检阴性者 (对照组 4 0例 )共 1 2 0例 ,均在胆囊切除术前后测定血浆内毒素水平。结果 :术前革兰氏阴性菌感染组血浆内毒素水平明显高于革兰氏阳性菌感染组和对照组 (P <0 .0 1 ) ,革兰氏阳性菌感染组与对照组之间无明显差异 (P >0 .0 5) ;术后革兰氏阴性菌感染组血浆内毒素水平很快下降与术前比较有极显著差异 (P <0 .0 1 )。结论 :血浆内毒素定量测定 ,可作为判断胆汁感染轻重程度和观察治疗效果的指标。 展开更多
关键词 胆汁细菌感染 内毒素 革兰氏阴 胆囊切除
下载PDF
熊胆粉联合西药治疗婴儿巨细胞病毒感染相关胆汁淤积性肝炎 被引量:6
4
作者 刘艳红 闫安平 贾美云 《中国实验方剂学杂志》 CAS 北大核心 2012年第15期300-302,共3页
目的:评价熊胆粉联合更昔洛韦治疗婴儿巨细胞病毒(CMV)感染相关胆汁淤积性肝炎的治疗效果。方法:将46例婴儿巨细胞病毒感染相关胆汁淤积性肝炎患儿随机分为治疗组24例与对照组22例。两组均给予更昔洛韦5 mg·kg-1,12 h/次等综合对... 目的:评价熊胆粉联合更昔洛韦治疗婴儿巨细胞病毒(CMV)感染相关胆汁淤积性肝炎的治疗效果。方法:将46例婴儿巨细胞病毒感染相关胆汁淤积性肝炎患儿随机分为治疗组24例与对照组22例。两组均给予更昔洛韦5 mg·kg-1,12 h/次等综合对症治疗。治疗组在此基础上加用熊胆粉0.02 g·kg-1口服,2次/d,均连用14 d,观察结果。结果:治疗组治疗前后比较血清总胆汁酸、血清总胆红素、直接胆红素、肝内胆管宽度差异有统计学意义(P<0.01),对照组治疗前后直接胆红素、胆汁酸、肝内胆管宽度无统计学意义;两组黄疸开始消退时间、黄疸完全消退时间之间差异有非常显著性意义(P<0.01)。结论:熊胆粉可以降低总胆红素和直接胆红素,降低胆汁酸水平,减轻肝功能损伤,减轻胆管扩张,促进黄疸消退。 展开更多
关键词 婴儿 巨细胞病毒感染相关胆汁淤积肝炎 熊胆粉
原文传递
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? 被引量:1
5
作者 Daniel Smyk Eirini I Rigopoulou +4 位作者 Yoh Zen Robin Daniel Abeles Charalambos Billinis Albert Pares Dimitrios P Bogdanos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第35期4855-4865,共11页
Primary biliary cirrhosis (PBC) is a progressive cho- lestatic liver disease characterized by the immune- mediated destruction of biliary epithelial cells in small intrahepatic bile ducts. The disease is characteriz... Primary biliary cirrhosis (PBC) is a progressive cho- lestatic liver disease characterized by the immune- mediated destruction of biliary epithelial cells in small intrahepatic bile ducts. The disease is characterized by circulating antimitochondrial antibodies (AMAs) as well as disease-specific antinuclear antibodies, cholestatic liver function tests, and characteristic histological fea- tures, including granulomas. A variety of organisms are involved in granuloma formation, of which mycobacte- ria are the most commonly associated. This has led to the hypothesis that mnycobacteria may be involved in the pathogenesis of PBC, along with other infectious agents. Additionally, AMAs are found in a subgroup of patients with rnycobacterial infections, such as lep- rosy and pulmonary tuberculosis. Antibodies against species-specific mycobacterial proteins have been re- ported in patients with PBC, but it is not clear whether these antibodies are specific for the disease. In addi- tion, data in support of the involvement of the role of molecular mimicry between rnycobacterial and human mitochondrial antigens as triggers of cross-reactive im- mune responses leading to the loss of immunological tolerance, and the induction of pathological features have been published. Thus, antibodies against myco- bacterial heat shock protein appear to cross-recognize AMA-specific autoantigens, but it is not clear whether these autoantibodies are mycobacterium-species-spe- cific, and whether they are pathogenic or incidental. The view that mycobacteria are infectious triggers of PBC is intriguing, but the data provided so far are not conclusive. 展开更多
关键词 Antimitochondrial antibodies AUTOANTIBODY AUTOIMMUNITY CHOLESTASIS Heat shock Infection Liverdisease Liver failure MYCOBACTERIUM TUBERCULOSIS
下载PDF
Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis
6
作者 Ahmet Dobrucali Rafet Yigitbasi +3 位作者 Yusuf Erzin Oguzhan Sunamak Erdal Polat Hakan Yakar 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第20期3076-3077,共2页
Fasciola hepatica,an endemic parasite in Turkey,is still a very rare cause of cholestasis worldwide.Through ingestion of contaminated water plants like watercress,humans can become the definitive host of this parasite... Fasciola hepatica,an endemic parasite in Turkey,is still a very rare cause of cholestasis worldwide.Through ingestion of contaminated water plants like watercress,humans can become the definitive host of this parasite.Cholestatic symptoms may be sudden but in some cases they may be preceeded by a long period of fever,eosinophilia and vague gastrointestinal symptoms.We report a woman with cholangitis symptoms of sudden onset which was proved to be due to Fasciola hepatica infestation by an endoscopic retrograde cholangiography. 展开更多
关键词 Adult ANIMALS Antiplatyhelmintic Agents Bithionol Cholangiopancreatography Endoscopic Retrograde Cholestasis Extrahepatic Fasciola hepatica purification FASCIOLIASIS Female Humans
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部